{"transactions":[{"id":2022289,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-02-10T22:22:45.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":10000,"price":0.8,"value":8000.0,"ownership":{"direct":true},"balance_after":82267,"source":{"system":"sec-edgar","filing":"0001567619-23-002404","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761923002404/doc1.xml","form_type":"4"}},{"id":2065975,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-04T22:43:27.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":40690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock units represents a contingent right to receive one share of the lssuers common stock, following its vesting of one-third on 01/01/24? 01/01/25 and 01/01/26, upon the earlier of termination of employment? the third anniversary of the award date? a change in control, or the reporting persons death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock units represents a contingent right to receive one share of the lssuers common stock, following its vesting of one-third on 01/01/24? 01/01/25 and 01/01/26, upon the earlier of termination of employment? the third anniversary of the award date? a change in control, or the reporting persons death."}],"balance_after":440328,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":40690},"source":{"system":"sec-edgar","filing":"0001567619-23-000326","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761923000326/doc1.xml","form_type":"4"}},{"id":2065974,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-04T22:43:27.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":55107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock units represents a contingent right to receive one share of the lssuers common stock, following its vesting on 01/01/24, upon the earlier of termination of\nemployment? the third anniversary of the award date? a change in control, or the reporting persons death,"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock units represents a contingent right to receive one share of the lssuers common stock, following its vesting on 01/01/24, upon the earlier of termination of\nemployment? the third anniversary of the award date? a change in control, or the reporting persons death,"}],"balance_after":399638,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":55107},"source":{"system":"sec-edgar","filing":"0001567619-23-000326","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761923000326/doc1.xml","form_type":"4"}},{"id":2065973,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-04T22:43:27.000Z","date":"2022-12-31","kind":"grant","acquired":true,"shares":10851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment? the third anniversary of the award date? a change of control? or the reporting person's death. These restricted stock units vest on date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment? the third anniversary of the award date? a change of control? or the reporting person's death. These restricted stock units vest on date of grant."}],"balance_after":344531,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10851},"source":{"system":"sec-edgar","filing":"0001567619-23-000326","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761923000326/doc1.xml","form_type":"4"}},{"id":2138982,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-10-11T13:35:09.000Z","date":"2022-10-06","kind":"tax_withholding","acquired":false,"shares":4163,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":72267,"source":{"system":"sec-edgar","filing":"0001567619-22-018383","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761922018383/doc1.xml","form_type":"4"}},{"id":2138981,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-10-11T13:35:09.000Z","date":"2022-10-06","kind":"exercise","acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of restricted stock."}],"balance_after":76430,"source":{"system":"sec-edgar","filing":"0001567619-22-018383","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761922018383/doc1.xml","form_type":"4"}},{"id":2146996,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-10-03T20:55:54.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":10850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":333680,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10850},"source":{"system":"sec-edgar","filing":"0001567619-22-018059","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761922018059/doc1.xml","form_type":"4"}},{"id":2175856,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-08-23T20:34:06.000Z","date":"2022-08-16","kind":"gift","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":63930,"source":{"system":"sec-edgar","filing":"0001567619-22-016598","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761922016598/doc1.xml","form_type":"4"}},{"id":2214004,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-05T21:40:14.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":20064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":322830,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":20064},"source":{"system":"sec-edgar","filing":"0001567619-22-013684","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761922013684/doc1.xml","form_type":"4"}},{"id":2299223,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-11T21:56:38.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":247841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted Stock Units (RSUs) vest upon achievement of certain performance goals. The grant of 136,632 RSUs are subject to shareholder approval of the Issuer's 2019 Omnibus Incentive Plan (the \"Plan\") to increase the authorized shares under the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Restricted Stock Units (RSUs) vest upon achievement of certain performance goals. The grant of 136,632 RSUs are subject to shareholder approval of the Issuer's 2019 Omnibus Incentive Plan (the \"Plan\") to increase the authorized shares under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The previous filing understated this number. This new total accurately reflects the cumulative total of Restricted Stock Units for the reporting person."}],"balance_after":302766,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":247841},"source":{"system":"sec-edgar","filing":"0001567619-22-008367","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761922008367/doc1.xml","form_type":"4"}},{"id":2307316,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-04T21:50:31.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":10715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":37781,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10715},"source":{"system":"sec-edgar","filing":"0001567619-22-007993","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761922007993/doc1.xml","form_type":"4"}},{"id":2307315,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-04T21:50:31.000Z","date":"2021-11-01","kind":"grant","acquired":true,"shares":4286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":27066,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4286},"source":{"system":"sec-edgar","filing":"0001567619-22-007993","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761922007993/doc1.xml","form_type":"4"}},{"id":2307314,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-04-04T21:50:31.000Z","date":"2022-03-31","kind":"gift","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares previously reported as indirectly held by Elion Oncology were transferred to the reporting person's direct holdings in an transaction exempt from Section 16 reporting."}],"balance_after":70930,"source":{"system":"sec-edgar","filing":"0001567619-22-007993","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761922007993/doc1.xml","form_type":"4"}},{"id":2441066,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-06T22:24:17.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":6722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Amendment is being filed to correct the balance in Box 9 - this should have reflected a cumulative balance."}],"balance_after":22780,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6722},"source":{"system":"sec-edgar","filing":"0001567619-22-000773","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761922000773/doc1.xml","form_type":"4/A","original_submission_date":"2022-01-04"}},{"id":2441064,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-06T21:03:09.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":6024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Amendment is being filed to correct the balance in Box 9 - this should have reflected a cumulative balance."}],"balance_after":16058,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6024},"source":{"system":"sec-edgar","filing":"0001567619-22-000718","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761922000718/doc1.xml","form_type":"4/A","original_submission_date":"2021-10-04"}},{"id":2447601,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-04T22:29:43.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":6722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":6722,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6722},"source":{"system":"sec-edgar","filing":"0001567619-22-000296","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761922000296/doc1.xml","form_type":"4"}},{"id":2545290,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-10-08T20:34:45.000Z","date":"2021-10-06","kind":"tax_withholding","acquired":false,"shares":4663,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9387,"source":{"system":"sec-edgar","filing":"0001567619-21-018171","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761921018171/doc1.xml","form_type":"4"}},{"id":2545289,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-10-08T20:34:45.000Z","date":"2021-10-06","kind":"exercise","acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of restricted stock."}],"balance_after":14500,"source":{"system":"sec-edgar","filing":"0001567619-21-018171","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761921018171/doc1.xml","form_type":"4"}},{"id":2551322,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2021-10-04T20:47:48.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":6024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":6024,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6024},"source":{"system":"sec-edgar","filing":"0001567619-21-017831","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761921017831/doc1.xml","form_type":"4"}},{"id":2636804,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-09T20:47:16.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":1907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":10034,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10034},"source":{"system":"sec-edgar","filing":"0001567619-21-013195","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761921013195/doc1.xml","form_type":"4"}},{"id":2636803,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-09T20:47:16.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":12858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest upon achievement of certain performance goals."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vest upon achievement of certain performance goals."}],"balance_after":12858,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12858},"source":{"system":"sec-edgar","filing":"0001567619-21-013195","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761921013195/doc1.xml","form_type":"4"}},{"id":2636802,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-09T20:47:16.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":8572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in two equal installments beginning July 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units vest in two equal installments beginning July 1, 2022."}],"balance_after":8572,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8572},"source":{"system":"sec-edgar","filing":"0001567619-21-013195","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761921013195/doc1.xml","form_type":"4"}},{"id":2658390,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-06-22T22:07:57.000Z","date":"2021-06-22","kind":"purchase","acquired":true,"shares":2000,"price":7.0292,"value":14058.4,"ownership":{"direct":true},"balance_after":28000,"source":{"system":"sec-edgar","filing":"0001567619-21-012496","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761921012496/doc1.xml","form_type":"4"}},{"id":2673447,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":117038,"kind":"person","name":"Floyd Robert Michael","position":1,"cik":"0001828217","reported_name":"Floyd Robert Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2021-06-10T21:09:21.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":8127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":8127,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8127},"source":{"system":"sec-edgar","filing":"0001567619-21-011982","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761921011982/doc1.xml","form_type":"4"}}]}